INZY - Inozyme Pharma  - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

INZY is currently covered by 5 analysts with an average price target of $14.24. This is a potential upside of $10.24 (256%) from yesterday's end of day stock price of $4.

Inozyme Pharma 's activity chart (see below) currently has 31 price targets and 40 ratings on display. The stock rating distribution of INZY is 90% BUY and 10% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 21.43% with an average time for these price targets to be met of 9.29 days.

Highest price target for INZY is $4, Lowest price target is $4, average price target is $4.

Most recent stock forecast was given by TIAGO FAUTH from WELLS FARGO on 19-May-2025. First documented stock forecast 18-Aug-2020.

Currently out of the existing stock ratings of INZY, 9 are a BUY (90%), 1 are a HOLD (10%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

$4

6 months 27 days ago
(19-May-2025)

1/2 (50%)

$0.01 (0.25%)

38

Buy

7 months 2 days ago
(14-May-2025)

0/8 (0%)

$18.21 (380.17%)

Buy

8 months 6 days ago
(10-Apr-2025)

0/8 (0%)

$9.77 (230.97%)

Buy

$15

9 months 6 days ago
(10-Mar-2025)

0/5 (0%)

$9.77 (186.81%)

Buy

$40

11 months 3 days ago
(13-Jan-2025)

0/1 (0%)

$22.69 (131.08%)

Show more analysts

Please expand the browser size to see the chart

What is INZY (Inozyme Pharma ) average time for price targets to be met?

On average it took 9.29 days on average for the stock forecasts to be realized with a an average price target met ratio 21.43

Which analyst has the current highest performing score on INZY (Inozyme Pharma ) with a proven track record?

SUJI JEONG

Which analyst has the current lower performing score on INZY (Inozyme Pharma ) with a proven track record?

TIAGO FAUTH

Which analyst has the most public recommendations on INZY (Inozyme Pharma )?

Suji Jeong has 7 price targets and 4 ratings on INZY

Which analyst is the currently most bullish on INZY (Inozyme Pharma )?

Tazeen Ahmad with highest potential upside - $10

Which analyst is the currently most reserved on INZY (Inozyme Pharma )?

David Nierengarten with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?